<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01227083</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-GEN-OBS-10-178</org_study_id>
    <nct_id>NCT01227083</nct_id>
  </id_info>
  <brief_title>2nd_Computerized Asthma Specific Quality of Life(cAQOL)</brief_title>
  <acronym>2nd_cAQOL</acronym>
  <official_title>Comparison of the Responsiveness of Two Different Asthma-specific QOL Measures (AQLQ and cAQOL) in Korean Patients With Persistent Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dong-A University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of the responsiveness of two different asthma-specific QOL measures (AQLQ and
      cAQOL) in Korean patients with persistent asthma
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Two asthma quality of life measurement tool</measure>
    <time_frame>24 weeks treatment</time_frame>
    <description>Two asthma quality of life measurement tool (cAQOL, AQLQ) and the correlation between ACT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between cAQOL/AQLQ</measure>
    <time_frame>treatment screening, week1,week12,week24</time_frame>
    <description>-Correlation between cAQOL/AQLQ and other clinical parameters including FEV1, and asthma exacerbation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of asthma control therapy and a questionnaire</measure>
    <time_frame>24 weeks treatment</time_frame>
    <description>-The proportion of subjects with achieving well controlled asthma within ACT &amp; cAQOL-guided management strategy with ICS or ICS/LABA based on GINA 2006 guidelines during 24 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>asthma patient genotypes</measure>
    <time_frame>Screening</time_frame>
    <description>Sub-group of ADRB2 and NK2R genotypes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Persistent Asthma Patient</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Asthma control test check AQLQ(Asthma Quality of Life Questionnaire)after being cAQOL(Computerized Asthma specific quality of life)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Asthma control test check cAQOL(Computerized Asthma specific quality of life)after being AQLQ(Asthma Quality of Life Questionnaire)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sub-group of ADRB2 and NK2R genotypes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        asthma control patient
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 20-70 years

          -  Patient diagnosed with asthma over six months ago

          -  Asthma diagnosis

               -  Airway reversibility, FEV1 ≥ 12% and 200mL or

               -  Airway hyper-responsiveness, PC20 &lt; 16 mg/mL or

               -  More than two weeks, more than 2 times a day in excess of 20% PEFR diurnal
                  variability patient

          -  FEV1 55-100% of predicted value patient

          -  Inhaled corticosteroids alone or inhaled corticosteroids and beta agonists used
             patient

          -  Currently, at least if you have one or more asthma symptoms, asthma control test (ACT
             • Asthma Control Test) score of less than 19 characters

          -  Patients who sufficiently listen to the purpose and content of this trial and the
             properties of investigational products and voluntarily agree with the participation to
             sign a written consent approved by IRB of Ajou University Medical Center before the
             participation in this trial

        Exclusion Criteria:

          -  Current smoking or smoking in the past 15packyears

          -  Patients who show a symptom of an acute disease within 14 days before the beginning of
             this trial (administration of trial medication)

          -  Recent changes in asthma treatment for 28days

          -  Chronic diseases that affect the quality of life
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hae-Sim Park, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ajou University Medical Center</name>
      <address>
        <city>Suwon</city>
        <zip>443-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2010</study_first_submitted>
  <study_first_submitted_qc>October 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2010</study_first_posted>
  <last_update_submitted>November 10, 2013</last_update_submitted>
  <last_update_submitted_qc>November 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Hae-Sim Park</investigator_full_name>
    <investigator_title>Professor, Department of Surgery, Ajou University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>AQLQ and cAQOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

